Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma

4 Jan 2024

Abstract excerpt

Abstract S-palmitoylases and S-depalmitoylases are differentially expressed in various cancers and several malignant tumors and show a strong prognostic ability. Notwithstanding, the potential clinical impact of S-palmitoylases and S-depalmitoylases, particularly in the prognosis and progression of lung adenocarcinoma (LUAD), has not been clarified. Expression levels of S-palmitoylases and S-depalmitoylases in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38177255
DOI: 10.1038/s41598-024-51182-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinomaPMID 38177255Read ↗

Single-cell RNA sequencing reveals palmitoylation-driven cellular heterogeneity and prognostic biomarkers in lung adenocarcinomaSemantic proximity Read ↗

Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesisSemantic proximity Read ↗

Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune responseSemantic proximity Read ↗

Lipid metabolism gene-wide profile and survival signature of lung adenocarcinomaSemantic proximity Read ↗

Detection of the Fatty Acid Metabolism‐Linked Genes in Lung Adenocarcinoma as Biomarkers for Clinical Prognosis and Immunotherapeutic TargetsSemantic proximity Read ↗

Identification of palmitoylation-related lncRNAs as prognostic biomarkers and immune modulators in liver cancerSemantic proximity Read ↗

Research progress on S-palmitoylation modification mediated by the ZDHHC family in glioblastomaSemantic proximity Read ↗

The novel palmitoylation modification learning reveals ZDHHC5 promotes the progression of bladder cancer through the immune microenvironment：Muti-omics analysis combine with machine learningSemantic proximity Read ↗

Lipid metabolism gene-wide profile and survival signature of lung adenocarcinomaSemantic proximity Read ↗

Systematic analysis of ZDHHC9 as a potential prognostic and immunotherapy biomarker in breast cancerSemantic proximity Read ↗

PTGDS is a potential marker for lung adenocarcinoma identified from multi-omics pan-cancer dataSemantic proximity Read ↗

Molecular Subgroup Establishment and Signature Creation of lncRNAs Associated with Acetylation in Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.